According to a recent article in the Daily Mail, researchers from the University of Chicago are reporting that Masitinib, a cheap drug costing around US$3 per pill, may be an effective way of treating people who have COVID.
During laboratory testing, the researchers found that the inexpensive drug actually stopped the COVID virus from replicating, which is the essentially how the virus causes us to get sick.
It was even shown to be effective against the COVID variants.
There is only one catch, though, the drug is used to treat cancer in dogs and has not been approved for human use.
The discovery is part of research that scientists are conducting on Masitinib, as they believe it may also be an effective treatment for Alzheimer’s, skin cancer and perhaps even multiple sclerosis.
READ: Could a drug given to dogs to treat cancer fight Covid? Scientists discover £2 medicine can stop virus replicating and causing disease
WARNING UPDATE: Though several studies suggest Ivermectin may be an effective treatment for COVID, there is increasing evidence that people are self-medicating with the drug, overdosing and poisoning themselves. This is a drug, and it should not be taken without a doctor’s prescription. READ: Kansas medical experts warn against rising self-use of ivermectin to treat COVID-19 AND CDC warns of increased Ivermectin overdoses
Original Article continues here….
This is not the first time a drug, made for animals, ended up being an effective medicine for people.
Ivermectin started off as a treatment for parasites in animals and was eventually approved for human use, where it is often prescribed for parasites and tropical diseases. Ivermectin has been used for years.
And recent studies are indicating that Ivermectin may also be effective in combatting COVID. READ: French Pasteur Institute study shows how well Ivermectin can treat COVID-19 infection AND Ivermectin, The Drug That Cracked COVID and Treated President Trump AND Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin
Reblogged this on Independent Citizens.